SAN FRANCISCO (MedPage Today) -- The rate of venous thromboembolism was halved after hip or knee arthroplasty by the investigational oral anticoagulant rivaroxaban (Xarelto) compared with enoxaparin (Lovenox), said a researcher here.
ASH: Investigational Drug Beats Enoxaparin for Post-Surgery Thro...Courtesy MedPage Today Surgery Thu, 12/11/2008 - 13:10
SAN FRANCISCO (MedPage Today) -- The rate of venous thromboembolism was halved after hip or knee arthroplasty by the investigational oral anticoagulant rivaroxaban (Xarelto) compared with enoxaparin (Lovenox), said a researcher here. More related itemsOral Factor Xa Inhibitor Prevents Post-Surgical...
Early Rehab Speeds Knee Replacement Recovery (CME/CE)
Oral Drug Reduces VTE Risk After Hip Replacement...
Burt's Bees - Baby Bee Buttermilk Lotion, 7 fl oz...
ghd MK4 Professional Advanced Ceramic Heat-Styler, 1"
|
Post new comment